Evidence map›Paper›PMID 37444486›Full record

ArticleCancers2023

Explainable CAD System for Classification of Acute Lymphoblastic Leukemia Based on a Robust White Blood Cell Segmentation.

Jose Luis Diaz Resendiz, Volodymyr Ponomaryov, Rogelio Reyes Reyes, Sergiy Sadovnychiy

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jose Luis Diaz ResendizInstituto Politecnico Nacional, Escuela Superior de Ingenieria Mecanica y Electrica-Culhuacan, Av. Sta. Ana 1000, Mexico City 04440, Mexico.ORCID 0000-0002-8692-7709
Volodymyr PonomaryovInstituto Politecnico Nacional, Escuela Superior de Ingenieria Mecanica y Electrica-Culhuacan, Av. Sta. Ana 1000, Mexico City 04440, Mexico.ORCID 0000-0003-4477-4676
Rogelio Reyes ReyesInstituto Politecnico Nacional, Escuela Superior de Ingenieria Mecanica y Electrica-Culhuacan, Av. Sta. Ana 1000, Mexico City 04440, Mexico.ORCID 0000-0001-5506-6611
Sergiy SadovnychiyInstituto Mexicano del Petroleo, Eje Central Lazaro Cardenas Norte 152, Mexico City 07730, Mexico.ORCID 0000-0001-5219-1150
Instituto Politécnico Nacional · MXMexican Institute of Petroleum · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukemia is a significant health challenge, with high incidence and mortality rates. Computer-aided diagnosis (CAD) has emerged as a promising approach. However, deep-learning methods suffer from the "black box problem", leading to unreliable diagnoses. This research proposes an Explainable AI (XAI) Leukemia classification method that addresses this issue by incorporating a robust White Blood Cell (WBC) nuclei segmentation as a hard attention mechanism. The segmentation of WBC is achieved by combining image processing and U-Net techniques, resulting in improved overall performance. The segmented images are fed into modified ResNet-50 models, where the MLP classifier, activation functions, and training scheme have been tested for leukemia subtype classification. Additionally, we add visual explainability and feature space analysis techniques to offer an interpretable classification. Our segmentation algorithm achieves an Intersection over Union (IoU) of 0.91, in six databases. Furthermore, the deep-learning classifier achieves an accuracy of 99.9% on testing. The Grad CAM methods and clustering space analysis confirm improved network focus when classifying segmented images compared to non-segmented images. Overall, the proposed visual explainable CAD system has the potential to assist physicians in diagnosing leukemia and improving patient outcomes.

Indexed as

acute lymphoblastic leukemiadeep-learningleukemia classificationnuclei segmentationXAI

Identifiers

PMID37444486
PMCPMC10340488
OpenAlexW4382402221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.